Immune complexes and immunoconglutinin interactions associated with altered lymphocyte activity in Plasmodium chabaudi infections.
Fresh plasma from rats infected with Plasmodium chabaudi, incubated with splenic lymphocytes from rats immunized 5 days previously with sheep blood cells, suppressed the capacity of the spleen cells to produce antibody against the sheep cells as was indicated by reductions in the numbers of hemolytic Jerne plaques formed by the treated cells. The effect was maximal in plasma of rats drawn on the 7th day of infection at a time the rats experienced a hemolytic crisis. Serologic studies indicated that the active plasma contained elevated titers of antibody against fibrinogen products, antibody against the soluble serum antigens elaborated during blood infections and antibody against the third component of fixed complement (C3) or immunoconglutinin. Titers of lytic complement were reduced and amounts of soluble immune complex precipitated with polyethylene glycol 6000 were elevated. The active plasma may have affected the antibody producing cells by one or both of two mechanisms. Soluble antigen-antibody complexes could have interacted with Fc receptors of activated lymphocytes to alter their function. Alternatively, the complexes may have fixed complement and interacted with receptors for fixed C3 on the lymphocyte membrane. Such cells, being coated with the antigen for immunoconglutinin, could be altered by immunoconglutination. Inasmuch as the immune complexes in the active plasma were generated in vivo, it would seem unlikely that the plasma would contain significant amounts of complex that had not fixed complement. With immunoconglutinin present in the plasma, alteration of the cells by immunoconglutination seems a more likely possibility.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D000936:Antigen-Antibody Complex / Q000276:immunology*; D003168:Complement Fixation Tests; D003165:Complement System Proteins / Q000032:analysis; D004906:Erythrocyte Count; D005340:Fibrinogen / Q000276:immunology; D006462:Hemolytic Plaque Technique; D037561:Immunoconglutinins; D007136:Immunoglobulins / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology*; D008288:Malaria / Q000097:blood / Q000276:immunology*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013154:Spleen / Q000166:cytology
D000906:Antibodies; D000936:Antigen-Antibody Complex; D037561:Immunoconglutinins; D007136:Immunoglobulins; D005340:Fibrinogen; D003165:Complement System Proteins